Xenon Pharmaceuticals (XENE) PT Lowered to $49 at Wedbush
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Price: $62.35 -2.93%
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Xenon Pharmaceuticals (NASDAQ: XENE) to $49.00 (from $50.00) while maintaining a Outperform rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Xenon Pharmaceuticals (XENE)
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
- Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
